Post Subject #512   It's to the point now I can't defend Spike5 05/30/17 11:40:24 AM #511   You're preaching to the choir vis-á-vis Ocaliva. I'm DewDiligence 03/13/17 12:02:37 PM #510   Dont forget, that OCALIVA has received approbation from osaffer 03/13/17 11:46:45 AM #509   Not a big deal, IMO: #msg-129405710. DewDiligence 03/13/17 09:37:58 AM #508   FXR agonist Cancer ? This is not good osaffer 03/13/17 08:43:12 AM #507   The CC slides have only the design outline DewDiligence 02/23/17 11:23:57 AM #506   ICPT 4Q16 CC slides: DewDiligence 02/23/17 11:23:06 AM #505   ICPT -8% on 4Q16 results: #msg-128940872. DewDiligence 02/23/17 11:13:31 AM #504   Just listen and watch the slides ... osaffer 02/17/17 07:39:47 AM #503   I am not based in France. osaffer 02/17/17 07:39:11 AM #502   Analyst Activity – Wedbush Reiterates Outperform on Intercept trendmkr 02/16/17 03:06:04 PM #501   Intervention? More like nonsensical biased vomiting. ThreeF21 02/16/17 10:45:40 AM #500   Wow, you can only say that in response osaffer 02/16/17 08:33:35 AM #499   Blah Blah Blah Go back to your hole froggy ThreeF21 02/15/17 11:16:20 AM #498   While ICPT has started its phase 3 several osaffer 02/15/17 04:25:57 AM #497   Comments on new protocol of REGENERATE trial: #msg-128603305. DewDiligence 02/10/17 12:05:56 PM #496   ICPT CEO sold $5.8M of stock when AGN-TBRA DewDiligence 09/23/16 09:58:14 AM #495   ICPT romanov5 08/02/16 08:05:48 AM #494   Target Price ICPT 58$ osaffer 07/07/16 02:54:29 AM #493   Huge convertible-debt offering: #msg-123610432. DewDiligence 06/29/16 04:44:15 PM #492   Which FIelD , Prurit Field ? Side Effects osaffer 06/28/16 03:48:40 AM #491   ICPT is the only player on the field. biotechhead 06/09/16 09:34:24 AM #490   1 in 1000 women over 40 affected. Off-label biotechhead 06/07/16 03:51:24 PM #489   Why is stock up $10 or 7% today? IPO$ 06/02/16 03:23:57 PM #488   But the good news with the approbation of osaffer 06/02/16 04:04:31 AM #487   I think what we can say is we Spike5 06/01/16 03:23:25 PM #486   PBC was not targeted by Genfit, but FDA osaffer 06/01/16 10:14:11 AM #485   Very small market ... 1.3 billion better than Spike5 05/31/16 05:18:19 PM #484   Very small market ... But enjoy ... osaffer 05/31/16 08:44:29 AM #483   Intercept Pharmaceuticals Inc. won approval for a drug IPO$ 05/30/16 09:23:06 AM #482   Intercept Pharma's Ocaliva Gets FDA Accelerated Approval For cooler 05/28/16 01:39:03 PM #481   How many points (up or down) is the KING T 05/24/16 11:17:58 AM #480   How many points (up or down) is everyone KING T 05/24/16 10:19:47 AM #479   Why is Genfit considered to be the partner osaffer 05/24/16 09:33:34 AM #478   Genfit CEO Interview osaffer 05/24/16 09:31:17 AM #477   ICPT has had a good history with FDA IPO$ 05/20/16 11:17:01 AM #476   Genfit Share should double soon osaffer 05/20/16 11:13:46 AM #475   For me there will be some restrictions for OCA osaffer 05/20/16 11:13:20 AM #474   Im short the May 27 130's IPO$ 05/12/16 02:20:42 PM #473   5/29/16 = GOOD or BAD FDA meeting? Anyone??? IPO$ 05/11/16 01:47:30 PM #472   ICPT Class Action Suite osaffer 05/03/16 07:47:20 AM #471   $80 PT? Ha ha ha ha sorkin 04/27/16 09:30:06 PM #470   Please check FR0004163111 GNFT not GNFT on grey market. osaffer 04/25/16 05:39:26 AM #469   Have fun navigating the $1 bid/ask spread on GNFTF. esedu 04/22/16 07:01:49 AM #468   Elafibranor in Cover in Gastroenterology in May 2016 osaffer 04/21/16 08:34:43 AM #467   Major Actors are mainly ICPT and Genfit ... osaffer 04/19/16 04:00:23 AM #466   Nonalcoholic Steatohepatitis (NASH) Therapeutics Market to Reach US$20.27 osaffer 04/19/16 03:57:29 AM #465   Weekly Biotech Report covering – Opko Health, Intercept venturecapp 04/11/16 02:05:57 PM #464   $4 billion market cap is too over priced. IPO$ 04/08/16 05:43:02 PM #463   Excellent point. IPO$ 04/08/16 05:42:29 PM Post Subject

© 2017 InvestorsHub.Com, Inc.